How his story helps shatter some of the common stereotypes about type 2 diabetes.

It seems that the ultimate goal of a GlucoSitter-integrated Medtronic pump would be a 24-hour closed-loop system that requires minimal or no user input (a “fully...

The two trillion dollar problem – a new report provides a groundbreaking look at the worldwide cost of obesity.

By Kelly Close Twitter Summary: @kellyclose speaks to @US_FDA in favor of PCSK9 inhibitor drug Praluent – need to bring more options to #PWD to fight against CV disease...

How a major research study is challenging an outdated FDA restriction.

Twitter summary: Major updates from @MDT_Diabetes on the 640G predictive #insulin suspend for #diabetes from #ATTD2015

Twitter summary: #DBminesummit brings together top minds to discuss innovations in #diabetes – top 6 highlights below, full report coming soon! This past week, our team...

Sleek design and a future meter + test strip subscription service – how this diabetes management solution hopes to stand out from the rest.

At the Consumer Electronic’s Show in Las Vegas, Dexcom presented the first mock-up we’ve ever seen of its Gen 5 CGM integrated directly with an Apple iPhone app and...

My reflections on a visionary, scientist, role model, and friend.

How you can tell drug and device makers what YOU want from diabetes products.

What does this controversial data mean for the type 2 diabetes epidemic?

New blinded sensor worn for 14 days that will give a detailed picture of your glucose levels.

Yesterday, Sanofi announced a partnership with Google Life Sciences to improve diabetes care through new sensors, wearable devices, and better software. The partnership...

Plus, exciting details on Google’s glucose-sensing contact lens!

Plus, my Resolutions for 2016!

Diagnoses stabilizing, though 83% of 65+ year olds have diabetes or prediabetes.

Our top takeaways from the health and medicine edition of the world-famous TED conference.

The 338-patient, Dexcom-sponsored DIaMonD Study aims to find out.

A new study from Dr. Doug Melton’s team provides hope for the future of stem cell treatment in diabetes. But there’s still a long way to go.